Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy

1. Vulsteke, C.
2. Chambers, S.K.
3. Pérez, M.J.R.
4. Chan, J.K.
5. Raaschou-Jensen, N.
6. Zhuo, Y.
7. Lorusso, D.
8. Herzog, T.J.
9. de la Motte Rouge, T.
10. Thomes Pepin, J.A.
11. Braicu, E.I.
12. Chen, L.-M.
13. Levy, T.
14. Barter, J.F.
15. Pilar Barretina-Ginesta, M.
16. Joosens, E.
17. York, W.
18. Malinowska, I.A.
19. González-Martín, A.
20. Monk, B.J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.EJCA.2024.114157 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus